Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endologix Inc. ELGXQ

Healthcare
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the... see more

Recent & Breaking News (OTCPK:ELGXQ)

Endologix Announces FDA Approval of First Percutaneous Indication for Endovascular Abdominal Aortic Aneurysm Repair

Globe Newswire April 16, 2013

Endologix Board Member Roderick de Greef to Retire; Thomas F. Zenty, III to Stand for Election as Board Member

Globe Newswire April 15, 2013

Endologix to Report First Quarter 2013 Financial Results on April 30, 2013

Globe Newswire April 8, 2013

Endologix to Present at the 25th Annual ROTH Conference

Troy Schwensen March 11, 2013

Endologix Reports 27% and 25% Revenue Growth for the Full Year and Fourth Quarter 2012

Troy Schwensen February 27, 2013

Endologix to Report Fourth Quarter and Full Year 2012 Financial Results on February 27, 2013

Troy Schwensen February 7, 2013

Endologix Announces Presentation of Data From PEVAR Randomized Trial

Troy Schwensen January 28, 2013

Endologix Receives CE Mark for Nellix(R) EndoVascular Aneurysm Sealing System

Troy Schwensen January 24, 2013

Endologix Announces Preliminary Fourth Quarter 2012 Revenues

Troy Schwensen January 7, 2013

Endologix to Present at the 31st Annual J.P. Morgan Healthcare Conference

Troy Schwensen January 3, 2013

Endologix Appoints Shelley B. Thunen Chief Financial Officer

Troy Schwensen January 2, 2013

Endologix IntuiTrak Delivery System Receives Shonin Approval for Marketing in Japan

Troy Schwensen December 31, 2012

Endologix Comments on Alleged Patent Infringement

Troy Schwensen December 31, 2012